Capillary Technologies India Limited has successfully completed its strategic acquisition of Session M Inc. and Session M Czech Republic s.r.o., marking a significant milestone in the company's expansion strategy. The acquisition was finalized on May 01, 2026, as per Indian Standard Time, following the completion of all closing conditions.

Acquisition Structure and Details

The acquisition involved the purchase of 100% shareholding in Session M Inc., which was previously a wholly owned subsidiary of Mastercard Inc., along with its wholly owned subsidiary Session M Czech Republic s.r.o. The transaction was structured through Capillary's wholly owned subsidiary, Capillary Pte. Ltd., and executed directly and through its step-down subsidiary, Capillary Technologies LLC.

Regulatory Compliance and Documentation

The completion follows the company's earlier disclosure filed on February 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously received approval for the investment in its wholly owned subsidiary for the purpose of this acquisition.

All required details under Regulation 30 of the SEBI LODR Regulations and Para A of Part A of Schedule III, along with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were submitted in the February 24, 2026 filing.

Corporate Structure Impact

Following the completion of this acquisition, both Session M Inc. and Session M Czech Republic s.r.o. have become wholly owned subsidiaries of Capillary Technologies India Limited. This includes their classification as step-down subsidiaries where applicable, further strengthening the company's international presence and operational capabilities.

The acquisition represents Capillary's continued focus on expanding its global footprint in the customer engagement and loyalty management sector, leveraging Session M's established market presence and technological capabilities.

Capillary technologies India Limited has announced its earnings conference call for the fourth quarter of fiscal year 2025-26, providing investors and analysts an opportunity to engage with management following the release of financial results.

Conference Call Details

The company has scheduled the earnings discussion for May 6, 2026, following the announcement of financial results for the quarter and year ended March 31, 2026. The call will provide stakeholders with insights into the company's performance and strategic direction.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed both major stock exchanges about the scheduled investor interaction.

Investor Access

The earnings conference call invitation and related materials will be made available on the company's official website at capillarytech.com/investors/. This ensures transparency and equal access to information for all stakeholders interested in the company's quarterly performance and future outlook.

The call represents a standard practice for listed companies to maintain regular communication with the investment community and provide detailed explanations of financial performance beyond the published results.